Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies

American Journal of Obstetrics and Gynecology

Volumn 192, Issue 6, 2005, Pages 1761-1767

  Avgidou, Kyriaki ^a   Papageorghiou, Aris ^a   Bindra, Renu ^a   Spencer, Kevin ^b   Nicolaides, Kypros H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b HAROLD WOOD HOSPITAL   (United Kingdom)

Author keywords

First trimester; Nuchal translucency; Screening; Serum free human chorionic gonadotrophin and pregnancy associated plasma protein A; Trisomy 21

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADOLESCENT; ADULT; CHROMOSOME DISORDER; CONTROLLED STUDY; EVALUATION; FEMALE; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TRISOMY 21;

EID: 20444468193     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.03.021     Document Type: Article

References (24)

1. H. Cuckle Integrating Down syndrome screening Curr Opin Obstet Gynaecol 13 2001 175 181
2. K.H. Nicolaides, G. Azar, D. Byrne, C. Mansur, and K. Marks Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy BMJ 304 1992 867 889
3. R.J.M. Snijders, P. Noble, N. Sebire, A. Souka, and K.H. Nicolaides UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation Lancet 351 1998 343 346
4. M.L. Brizot, R.J.M. Snijders, N.A. Bersinger, P. Kuhn, and K.H. Nicolaides Maternal serum pregnancy associated placental protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy Obstet Gynecol 84 1994 918 922
5. P.L. Noble, H.D. Abraha, R.J. Snijders, R. Sherwood, and K.H. Nicolaides Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness Ultrasound Obstet Gynecol 6 1995 390 395
6. K. Spencer, V. Souter, N. Tul, R. Snijders, and K.H. Nicolaides A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free ß-human chorionic gonadotropin and pregnancy-associated plasma protein-A Ultrasound Obstet Gynecol 13 1999 231 237
7. R. Bindra, V. Heath, A. Liao, K. Spencer, and K.H. Nicolaides One stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15,030 pregnancies Ultrasound Obstet Gynecol 20 2002 219 225
8. R.J.M. Snijders, K. Sundberg, W. Holzgreve, G. Henry, and K.H. Nicolaides Maternal age and gestation specific risk for trisomy 21 Ultrasound Obstet Gynecol 13 1999 167 170
9. A. Tabor, J. Philip, M. Madsen, J. Bang, E.B. Obel, and B. Norgaard-Pedersen Randomised controlled trial of genetic amniocentesis in 4,606 low-risk women Lancet 1 1986 1287 1293
10. S. Smidt-Jensen, M. Permin, J. Philip, C. Lundsteen, J.M. Zachary, and S.E. Fowler Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling Lancet 340 1992 1238 1244
11. C.A. Hecht, and E.B. Hook The imprecision in rates of Down syndrome by 1-year maternal age intervals: a critical analysis of rates used in biochemical screening Prenat Diagn 14 1994 729 738
12. K. Spencer, C.E. Spencer, M. Power, A. Moakes, and K.H. Nicolaides One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester BJOG 107 2000 1271 1275
13. D.A. Krantz, T.W. Hallahan, F. Orlandi, P. Buchanan, J.W. Larsen Jr., and J.N. Macri First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency Obstet Gynecol 96 2000 207 213
14. K. Spencer, C.E. Spencer, M. Power, C. Dawson, and K.H. Nicolaides Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one stop clinic: a review of three years prospective experience BJOG 110 2003 281 286
15. N.J. Wald, H.C. Watt, and A.K. Hackshaw Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters N Engl J Med 341 1999 461 467
16. N.J. Wald, C. Rodeck, A.K. Hackshaw, J. Walters, L. Chitty, A.M. Mackinson, and SURUSS Research Group First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) Health Technol Assess 7 2003 1 77
17. N.J. Wald, W.J. Huttly, and A.K. Hackshaw Antenatal screening for Down's syndrome with the quadruple test Lancet 361 2003 835 836
18. F.D. Malone, N.J. Wald, J.A. Canick, R.H. Ball, D.A. Nyberg, C.H. Comstock, and R. Bukowski First- and second-trimester evaluation of risk (FASTER) trial: principal results of the NICHD multicenter Down syndrome screening study Am J Obstet Gynecol 189 2003 S56
19. K.H. Nicolaides Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities Am J Obstet Gynecol 191 2004 45 67
20. K. Spencer Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome Ann Clin Biochem 38 2001 413 414
21. C.M. Sturgeon, A.R. Ellis, R. Al-Sadie, M. Logan, and M. Costa UK NEQAS for peptide hormones and related substances, Annual Review 2003 2004 UK NEQAS Edinburgh p. 79-83
22. K.H. Nicolaides Screening for fetal chromosomal abnormalities: need to change the rules Ultrasound Obstet Gynecol 4 1994 353 354
23. L.B. McCullough, and F.A. Chervenak Ethics in obstetrics and gynecology 1994 Oxford University Press Oxford (UK)
24. K.H. Nicolaides, K. Spencer, K. Avgidou, S. Faiola, and O. Falcon Multicentre study of first-trimester screening for trisomy 21 in 75821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening Ultrasound Obstet Gynecol 25 2005 221 226